2014. Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors. Clinics. 69, 4 (Apr. 2014), 294–303. DOI:https://doi.org/10.1590/clin.v69i4.79512.